The development and study of herbal composition for complex therapy of influenza A
Introduction. Influenza type A is a socially significant infectious disease. Viral variability, mutations and reassortment make vaccination difficult. New drugs for specific therapy need to be developed because resistance to the existing drugs has appeared. A number of plant extracts have antiviral...
Saved in:
| Main Authors: | A. Ali Alshami, A. V. Panov, S. A. Kedik, E. A. Amirgulova, E. N. Vetrova, E. A. Dorovskikh, T. Yu. Kovaleva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-09-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/2133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine
by: Timothy S. Vincent, et al.
Published: (2024-11-01) -
Smoking and serological response to influenza vaccine
by: Won Suk Choi, et al.
Published: (2024-12-01) -
Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice
by: V. V. Zarubaev, et al.
Published: (2020-05-01) -
Production and Immune Response Against Pandemic Influenza Candidate Vaccines as Preparedness Against the Circulating H5N1 Influenza Viruses
by: Paulo Lee Ho, et al.
Published: (2025-06-01) -
Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan
by: Naruhito Otani, et al.
Published: (2025-04-01)